Capstone Asset Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $2.77M | Sell |
70,221
-2,640
| -4% | -$104K | 0.08% | 309 |
|
|
2017
Q1 | $2.29M | Sell |
72,861
-2,334
| -3% | -$73.2K | 0.06% | 362 |
|
|
2016
Q4 | $2.35M | Sell |
75,195
-4,914
| -6% | -$154K | 0.07% | 337 |
|
|
2016
Q3 | $3.22M | Buy |
80,109
+1,020
| +1% | +$41K | 0.09% | 262 |
|
|
2016
Q2 | $2.63M | Buy |
79,089
+7,296
| +10% | +$243K | 0.08% | 299 |
|
|
2016
Q1 | $2.11M | Sell |
71,793
-3,480
| -5% | -$102K | 0.06% | 372 |
|
|
2015
Q4 | $1.98M | Buy |
75,273
+6,723
| +10% | +$177K | 0.06% | 398 |
|
|
2015
Q3 | $1.62M | Buy |
68,550
+1,770
| +3% | +$41.9K | 0.05% | 422 |
|
|
2015
Q2 | $1.59M | Sell |
66,780
-10,134
| -13% | -$241K | 0.05% | 451 |
|
|
2015
Q1 | $1.83M | Buy |
76,914
+3,120
| +4% | +$74.1K | 0.05% | 422 |
|
|
2014
Q4 | $1.57M | Buy |
73,794
+35,820
| +94% | +$761K | 0.05% | 461 |
|
|
2014
Q3 | $647K | Buy |
37,974
+240
| +0.6% | +$4.09K | 0.02% | 838 |
|
|
2014
Q2 | $540K | Sell |
37,734
-11,454
| -23% | -$164K | 0.02% | 1006 |
|
|
2014
Q1 | $608K | Sell |
49,188
-8,400
| -15% | -$104K | 0.02% | 916 |
|
|
2013
Q4 | $631K | Sell |
57,588
-46,950
| -45% | -$514K | 0.02% | 935 |
|
|
2013
Q3 | $1.21M | Sell |
104,538
-888
| -0.8% | -$10.3K | 0.03% | 663 |
|
|
2013
Q2 | $1.18M | Buy |
+105,426
| New | +$1.18M | 0.03% | 628 |
|